Cafergot
CAFERGOT®
(ergotamine tartrate and caffeine) Tablets, USP
WARNING: Serious and/or life-threatening peripheral ischemia has been associated with the coadministration of CAFERGOT® with potent CYP 3A4 inhibitors including protease inhibitors and macrolide antibiotics. Because CYP 3A4 inhibition elevates the serum levels of CAFERGOT®, the risk for vasospasm leading to cerebral ischemia and/or ischemia of the extremities is increased. Hence, concomitant use of these medications is contraindicated (see also CONTRAINDICATIONS and WARNINGS section).
DRUG DESCRIPTION
Each tablet for oral administration contains 1 mg ergotamine tartrate, USP, and 100 mg caffeine, USP.
ERGOTAMINE TARTRATE:
 |
Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenyl-methyl)-,(5' α)-, [R-(R*,R*)]-2,3- dihydroxy-butanedioate (2:1) (salt).
CAFFEINE:
 |
1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-.
Inactive ingredients include acacia, calcium carbonate, compressible sugar, confectioner's sugar (sucrose and corn starch), magnesium stearate, methylparaben, microcrystalline cellulose, povidone, propylparaben, sodium benzoate, sodium starch glycolate, starch (potato), sucrose, synthetic iron oxide, titanium dioxide and other ingredients.
Generic Name: Ergotamine Tartrate and Caffeine
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Living Better
Find the secrets to longer life.
Health Extras
Summer Headache Triggers
Does summer heat make your head feel like a pressure cooker? Get tips on how to cope with hot weather headaches.See more WebMD Videos »
Cafergot
Health Resources
Updated & New
RxList does not provide medical advice, diagnosis or treatment.